Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-14

FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)

View source ↗

Summary

FDA approved Walgreens' supplemental application to market NICOTINE POLACRILEX MINT (nicotine polacrilex), a mint-flavored nicotine replacement therapy product,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NICOTINE POLACRILEX MINT (nicotine polacrilex)

Snippet

SUPPL AP for NICOTINE POLACRILEX MINT (NICOTINE POLACRILEX)